Complications during the treatment of diabetic foot osteomyelitis

Suzanne A V van Asten1, Moez Mithani2, Edgar J G Peters3

  • 1Department of Plastic Surgery, University of Texas Southwestern Medical Center, Dallas, TX, USA; Department of Internal Medicine, VU Medical Center, Amsterdam, The Netherlands.

Abstract

Insights

Diabetic foot osteomyelitis (DFO) patients frequently experienced acute kidney injury (AKI), which was linked to worse outcomes. Rates of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE) were lower than previously reported.

Area of Science:

  • Infectious Diseases
  • Nephrology
  • Diabetology

Background:

  • Diabetic foot osteomyelitis (DFO) is a serious complication of diabetes, often requiring prolonged treatment.
  • Medical interventions for DFO can lead to various complications, impacting patient outcomes.
  • Understanding these complications is crucial for optimizing DFO management.

Purpose of the Study:

  • To identify and analyze complications arising from medical treatments in patients diagnosed with diabetic foot osteomyelitis (DFO).
  • To assess the incidence of acute kidney injury (AKI), antimicrobial-resistant infections (MRSA, VRE), and catheter-related issues in DFO patients.
  • To explore associations between complications and patient outcomes during a 12-month follow-up.

Main Methods:

  • A retrospective review of 143 patients with histopathology or culture-confirmed DFO.
  • Monitoring for acute kidney injuries (AKI), development of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE).
  • Tracking gastrointestinal and venous catheter-related complications over a 12-month follow-up period.

Main Results:

  • Forty-seven episodes of AKI were recorded, with half occurring during initial hospitalization, 29.8% linked to antimicrobial therapy.
  • Patients experiencing AKI showed higher rates of recurrent ulcerations (69.2%), infections (38.5%), and hospitalizations (43.6%).
  • Baseline MRSA rates in bone were 9.8%; resistant strains (MRSA/VRE) were found in 14.7% during follow-up, more common in re-hospitalized patients (52.6%).

Conclusions:

  • DFO patients frequently developed AKI, associated with poorer outcomes, though not definitively linked to antibiotic exposure.
  • The incidence of MRSA and VRE in DFO bone biopsies was lower than previously documented.
  • Effective management of DFO requires vigilant monitoring for complications like AKI and resistant infections.

Related Concept Videos

Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...
438
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.0K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
277
Endocarditis IV: Nursing Management01:29

Endocarditis IV: Nursing Management

Infective endocarditis (IE) is a chronic infection of the heart's endocardium, primarily affecting the heart valves. A detailed nursing assessment for a patient with IE involves collecting subjective and objective data to ensure an accurate diagnosis and timely intervention.Subjective DataThe nurse gathers information about the patient's symptoms and complaints during the subjective assessment. Patients with infective endocarditis often report non-specific symptoms that can mimic other...
423
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

 The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
422
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.1K